BN Business News
Add your company to Business Communicator →

BUSINESS NEWS

Search Business News

Find articles by title or summary.

11/23/2021

DOJ Proposes Update to Program Fraud Civil Remedies

The Department of Justice has issued a notice of proposed rulemaking to revise the definition of 'investigating official' in its Program Fraud regulations, expanding it to include inspectors general established since the regulations were implemented.

11/23/2021

OFAC Sanctions Actions Removed from SDN List

The US Department of the Treasury's Office of Foreign Assets Control (OFAC) has lifted sanctions on Burundi individuals, removing their names from the Specially Designated Nationals and Blocked Persons List (SDN List)

11/23/2021

Noramco Seeks Registration as Bulk Manufacturer of Controlled Substances

Noramco has submitted an application to the authorities to be registered as a bulk manufacturer of controlled substances, a key step towards obtaining the necessary permits. The company aims to produce basic classes of controlled substances, as outlined in the supplementary information provided.

11/23/2021

Interim Final Rules on Prescription Drug and Health Care Spending

The Department of Health and Human Services, Department of Labor, and Department of the Treasury are issuing interim final rules requiring group health plans and health insurance issuers to submit information about prescription drugs and health care spending, as mandated by the Consolidated Appropriations Act, 2021.

11/23/2021

CFTC Requests Public Comment on Swap Clearing Requirement Amid LIBOR Transition

The Commodity Futures Trading Commission (CFTC) is seeking public input on how to adjust its swap clearing requirement to address the shift from LIBOR and other interbank offered rates to alternative reference rates, such as overnight reference rates. The CFTC is looking for comments on how to adapt its rules to accommodate this transition.

11/22/2021

FDA Reclassifies Blood Lancets for Enhanced Safety

The US Food and Drug Administration (FDA) has issued a final order to reclassify four types of blood lancets, requiring enhanced safety measures and premarket notification for certain products, in an effort to ensure their safety and effectiveness.

11/22/2021

FDA Issues Final Order for Premarket Approval of Blood Lancets

The FDA is requiring manufacturers to submit a premarket approval application or product development protocol completion notice for blood lancets that were previously classified as Class I for single-use, multiple-patient use devices, now classified as Class III for multiple patient use.

11/22/2021

USPTO Delays Patent Fee Effective Date to January 1, 2023

The United States Patent and Trademark Office (USPTO) has delayed the effective date of a new patent fee, originally set to take effect on January 1, 2022, until January 1, 2023, due to a final rule published in the Federal Register on August 3, 2020.

11/19/2021

Oregon and Washington Pears to Face Higher Assessment Rate

The US Department of Agriculture has proposed a rule to increase the assessment rate for pears grown in Oregon and Washington, effective for the 2021-22 fiscal period and beyond, in line with a recommendation from the Fresh Pear Committee.

11/19/2021

NHTSA Requests Public Comment on New Information Collection for Government 5-Star Safety Ratings Label Consumer Research

The National Highway Traffic Safety Administration (NHTSA) is seeking public comment on its intention to request approval from the Office of Management and Budget (OMB) for a new collection of information related to consumer research on the Government 5-Star Safety Ratings section of the Monroney label, following a 60-day comment period that began on April 28, 2020, and received 4 public comments.

11/19/2021

GSA Invites Public Comment on Presidential Commission on the Supreme Court of the United States' Draft Report

The General Services Administration (GSA) is seeking written public comments on the draft report of the Presidential Commission on the Supreme Court of the United States, which will be reviewed and voted on during an upcoming public virtual meeting. The meeting will be live-streamed at www.whitehouse.gov/pcscotus/ and materials will be posted at the same website prior to the meeting.

11/19/2021

FDA Seeks Public Comment on Proposed Labeling Requirements for Certain Beers

The Food and Drug Administration is announcing a proposed collection of information that has been submitted to the Office of Management and Budget for review and clearance under the Paperwork Reduction Act of 1995. The FDA is seeking public comment on labeling requirements for certain beers subject to the FDA's jurisdiction.